Purpose of Evaluation
- Early detection of Human Platelet Antigen (HPA) incompatibility.
- Preventing intracranial hemorrhage (ICH) in the fetus or newborn.
- Determining the need for Intravenous Immunoglobulin (IVIG) therapy during pregnancy.
Book FNAIT Evaluation in Saudi Arabia | Lahalak Medical Platform
A vital screening for mothers at risk of platelet incompatibility, aimed at protecting the fetus from intracranial hemorrhage and ensuring safe management of high-risk pregnancies under expert supervision.
Scientific name: Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Evaluation
A comprehensive evaluation including HPA antibody testing for parents, establishing a preventive treatment protocol to avoid hemorrhagic complications in the fetus or neonate during current and future pregnancies.
Service type
Medical monitoring program
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- High-risk pregnancy consultant visit
- HPA antibody testing
- Preventive hemorrhage management plan
Medical Service Information
Target Groups
- Mothers with a history of a previous child affected by neonatal thrombocytopenia.
- Pregnant women with identified platelet antibodies.
- Families with a genetic history of fetal bleeding disorders.
Management Protocol
- Regular maternal blood tests to monitor antibody levels.
- Advanced ultrasound imaging to monitor fetal growth and signs of hemorrhage.
- Coordinated delivery planning to ensure appropriate platelet availability if needed.
Conditions & Notices
- Provide medical history of previous pregnancies
- Paternal testing may be required
Medical services you might also like
